FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - Immunization, Realm US

19,481 resources

Type: Text:

By Version

By Authority

 

Start Prev Rows 14000 - 14200 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuth
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7925Type of Complication (STD)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7650Type Of Complication (Rubella)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7538Type of Complication (Babesiosis)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7282Complications (Mumps)active2017-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7285Complications (Pertussis)active2017-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.20.2.4TransferDocumentTypeactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.34Patient Educationactive2024-06hl7
hl7.fhir.us.davinci-alertsR4ValueSet/notification-admit-eventDa Vinci Notification Admit Event ValueSettrial-use2inm2019-07hl7
hl7.fhir.us.davinci-alertsR4ValueSet/notification-discharge-eventDa Vinci Notification Discharge Event ValueSettrial-use2inm2019-07hl7
hl7.fhir.us.davinci-alertsR4ValueSet/notification-transfer-eventDa Vinci Notification Transfer Event ValueSettrial-use2inm2019-07hl7
hl7.fhir.us.davinci-alertsR4ValueSet/notification-eventDa Vinci Notification Event ValueSettrial-use2inm2019-07hl7
hl7.fhir.us.davinci-deqmR4ValueSet/gaps-statusDEQM Gaps In Care Gap Status Value Settrial-use4cqi2021-04hl7
hl7.fhir.us.davinci-deqmR4ValueSet/update-typeDEQM Update Type Value Settrial-use4cqi2020-08hl7
hl7.fhir.us.coreR4ValueSet/us-core-procedure-codeUS Core Procedure Codestrial-use3cgp2022-09hl7
hl7.fhir.us.coreR4ValueSet/us-core-goal-descriptionUS Core Goal Codestrial-use3cgp2022-09hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.1.11.14914Race Value Setactive2009-01
signal.core.r4R4ValueSet/healthcare-service-procedure-code-cptHealthCare Service Procedure Code CPTdraft1pahl7
hl7.fhir.us.registry-protocolsR4ValueSet/ConcomitantProceduresPerformedTypeConcomitant Procedures Performed Typeactivecic2023-11hl7
fhir.outburn.co.ilR4ValueSet/vs-condition-verification-statusCondition Verification Statusdrafthl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7108VPD Specimen Conditionactive2020-01
fhir.cdc.opioid-cds-r4R4ValueSet/conditions-documenting-sleep-disordered-breathingSleep disordered breathingactive2023-04hl7
fhir.cdc.opioid-cds-r4R4ValueSet/opioid-misuse-disordersOpioid misuse disordersactive2023-05hl7
fhir.cdc.opioid-cds-r4R4ValueSet/conditions-likely-terminal-for-opioid-prescribingConditions likely terminal for opioid prescribingactive2023-05hl7
fhir.ops-esaviR4ValueSet/DirOrgNotiVSCódigos PAHO para Direccionesactive2021-03hl7
signal.core.r4R4ValueSet/questionnaire-ccars-considerations-for-providersQuestionnaire CCARS Considerations For Providersdraft1pahl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.303Statin Combinationsactive2024-03hl7
hl7.fhir.us.breast-radiologyR4ValueSet/ConsistentWithQualifierVSConsistentWith Qualifier ValueSetactive2022-12hl7
hl7.fhir.us.breast-radiologyR4ValueSet/ConsistentWithVSConsistentWith ValueSetactive2022-12hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1038Sex (MFU)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6057Value Type (Syndromic Surveillance)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.5020Acknowledgment Code (HL7) (PHLIP)active2011-01
hl7.fhir.us.ccdaR4ValueSet/2.16.840.1.113883.11.20.9.31ConsultDocumentTypetrial-usecgp2018-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.87Interventions Related to Care Coordination, Consultationsactive2024-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3417Contact Type Hepatitis A (NETSS)active2011-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.822DigTx RelieVR inclusions I10active2024-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7851Contact Type (FDD)active2018-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2194Organisms (Combination Tests by Culture and Identification)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2195Organisms (Combination Tests for Nucleic Acid)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.120.11.1005HIV 1active2024-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6056Name Type (Syndromic Surveillance)active2012-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.1.11.159331Act Statusactive2016-01
hl7.fhir.us.mcodeR4ValueSet/mcode-tumor-morphology-code-max-vsTumor Morphology Code Max Value Setactive4cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-tumor-morphology-code-vsTumor Morphology Code Value Setactive4cic2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.3.88.12.3221.8.9Body Site Value Setactive2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.11.20.9.41Tobacco Useactive2014-12
hl7.fhir.us.davinci-vbprR4ValueSet/measure-contractual-statusMeasure Contractual Statustrial-use1cqi2025-07hl7
hl7.fhir.us.registry-protocolsR4ValueSet/CABGStatusCABG Statusactivecic2023-11hl7
hl7.fhir.us.breast-radiologyR4ValueSet/CorrespondsWithVSCorrespondsWith ValueSetactive2022-12hl7
fhir.dgmcR4ValueSet/counseling-type-codeCounseling Type Codedraft2024-07hl7
fhir.cdc.opioid-cds-r4R4ValueSet/substance-misuse-behavioral-counselingSubstance misuse behavioral counselingactive2023-05hl7
fhir.kenyaPSIGR4ValueSet/kenyaCountiesVSCounties in Kenyadraft2025-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7852Geographic Locationactive2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7202Country Imported From (NND)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3200Birth Countryactive2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3169Birth Country (TB)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7987Country of Product Acquisition (Brucellosis)active2022-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.646bwell COVID Vaccine CN_Allergyactive2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.24.7.14Clinically Important Bacteria and Fungiactive2024-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.24.7.281Bacterial Skin Commensalsactive2024-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1240.3Sexactive2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1099.30Care Team Member Functionactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.230Gestational Diabetes SNOMED CTactive2024-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7953Critical Infrastructure Sector (NND)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1010Microscopic Exam Culture Site (TB)active2008-01
signal.core.r4R4ValueSet/questionnaire-ccars-current-non-prescription-substance-useQuestionnaire CCARS Current Non-Prescription Substance Usedraft1pahl7
signal.core.r4R4ValueSet/questionnaire-ccars-current-primary-roleQuestionnaire CCARS Current Primary Roledraft1pahl7
signal.core.r4R4ValueSet/questionnaire-ccars-current-issuesQuestionnaire CCARS Current Issuesdraft1pahl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7190Current Sex (NND)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7682Smoking Status (RIBD)active2018-01
signal.core.r4R4ValueSet/encounter-statusEncounterStatustrial-use2pa2019-10hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.972Case Verification (TB)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3078Cyclosporiasis Signs Symptoms (FDD)active2008-01
fhir.ops-esaviR4ValueSet/CodigoMeDRAAntecedenteVSCódigo MedDRA de Antecedenteactive2021-03hl7
fhir.ops-esaviR4ValueSet/FormaVerificacionVSCódigo forma de Verificaciónactive2021-03hl7
fhir.ops-esaviR4ValueSet/GrupoEtnicoVSGrupo étnicoactive2021-03hl7
fhir.ops-esaviR4ValueSet/ProfesionalNotificadorVSTipo de Profesional Notificadoractive2021-03hl7
fhir.ops-esaviR4ValueSet/UnidadesDeMedidaVSUnidades de medidaactive2021-03hl7
fhir.virtually.healthcareR4ValueSet/facility-typeFacility Typedraft2025-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1099.11Medication Statusactive2024-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7268Data Elements (NND Gen V2)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7213PHIN Questions (BIDS)active2013-01
hl7.fhir.us.vrdrR4ValueSet/vrdr-date-of-death-determination-methods-vsDate of Death Determination Methods Value Setactivepher2024-10hl7
fhir.org.nz.ig.baseR4ValueSet/datumCodeDatum codeactive2025-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7633Day Care Setting (FDD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3261Death Location (Flu)active2009-01
hl7.fhir.us.registry-protocolsR4ValueSet/CardiovascularTreatmentDecisionCardiovascular Treatment Decision Optionsactivecic2023-11hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7173Campylobacter Species (BIDS)active2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7174Campylobacter Nonculture Test Type (BIDS)active2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7175E. coli Culture Isolate Id Serotype (BIDS)active2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7177E. coli Shiga Toxin Test Type (BIDS)active2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7178E. coli Shiga Toxin (BIDS)active2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7183Listeria Culture Species (BIDS)active2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7159Mexican Health Jurisdictions (BIDS)active2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7176STEC Nonculture Test Type (BIDS)active2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7171Salmonella Serogroup (BIDS)active2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7172Shigella Serogroup (BIDS)active2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7169US Mexico States (BIDS)active2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7181Vibrio Biotype (BIDS)active2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7182Vibrio Cholera Toxin Test Type (BIDS)active2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7179Vibrio Culture Species (BIDS)active2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7180Vibrio Serotype (BIDS)active2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7170Specimen Site (BIDS)active2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7166Binational Reporting Criteria (BIDS)active2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7167Case Transmission Mode (BIDS)active2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7168Notifiable Event Disease Condition (BIDS)active2013-01
hl7.fhir.us.davinci-pctR4ValueSet/PCTCoordinationTaskStatusReasonCodesPCT GFE Request Coordination Task Status Reason Codes ValueSettrial-usefm2025-08hl7
hl7.fhir.us.davinci-pctR4ValueSet/PCTContributorTaskStatusReasonCodesPCT GFE Contributor Task Status Reason Codes ValueSettrial-usefm2025-08hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7716Definitely Possibly No (RIBD)active2018-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.136Home or Facility Care Locationactive2022-03hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3253Obesity Severity (Flu)active2009-01
hl7.fhir.us.carin-bbR4ValueSet/NCPDPBrandGenericIndicatorNCPDP Brand Generic Indicator Value Settrial-usefm2025-02hl7
hl7.fhir.us.breast-radiologyR4ValueSet/DensityAbnormalityTypeVSDensity Abnormality Type ValueSetactive2022-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.530Low Dose Non Combo ICSactive2023-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.529Medium Dose Non Combo Asthma ICS Adultactive2023-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.528High Dose Non Combo ICS Adultactive2023-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7211Influenza Transmission Zones (PHLIP)active2013-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.46Abilityactive2024-06hl7
fhir.ops-esaviR4ValueSet/FormaFarmaceuticaVSIdentificación Formas Farmacéuticasactive2021-03hl7
fhir.ops-esaviR4ValueSet/ViaAdminMedicamentoVSVías de Administración de Medicamentosactive2021-03hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3290Vaccination Special Indication (IIS)active2010-01
hl7.fhir.us.carin-bbR4ValueSet/C4BBClaimPharmacyTeamRoleC4BB Claim Pharmacy CareTeam Role Value Settrial-usefm2025-02hl7
hl7.fhir.us.carin-bbR4ValueSet/C4BBClaimProfessionalAndNonClinicianCareTeamRoleC4BB Claim Professional And Non Clinician Care Team Role Value Settrial-usefm2025-02hl7
hl7.fhir.us.carin-bbR4ValueSet/C4BBClaimInstitutionalCareTeamRoleC4BB Claim Institutional Care Team Role Value Settrial-usefm2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1041Specimen Collection Method (HL7)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7788Food Freshness (Listeria)active2018-01
hl7.fhir.us.davinci-pdexR4ValueSet/PDexAdjudicationPDex Adjudicationinformativefm2025-06hl7
hl7.fhir.us.davinci-pctR4ValueSet/PCTAdjudicationVSPCT Adjudication Value Settrial-usefm2025-08hl7
hl7.fhir.us.carin-bbR4ValueSet/C4BBAdjudicationC4BB Adjudication Value Settrial-usefm2025-02hl7
hl7.fhir.us.davinci-pctR4ValueSet/PCTTotalPCT Total Value Settrial-usefm2025-08hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.3.5.20.1USDA Subject Descriptoractive2010-01
hl7.fhir.us.davinci-crdR4ValueSet/orderDetailCRD Order Detail Codes Value Settrial-use1fm2025-08hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7747Diabetes Statusactive2017-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.18Acute Respiratory Failureactive2020-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7473Diagnostic Lab Test Findings (NND)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7973Diagnostic Test Finding (Anthrax)active2020-01
hl7.fhir.us.vrdrR4ValueSet/vrdr-contributory-tobacco-use-vsContributory Tobacco Use ValueSetactivepher2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.134Sleep Related Symptom for Positive Airway Pressure Device Use Evaluationactive2022-03hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7753Directionality of Link (TB)active2017-12
signal.core.r4R4ValueSet/questionnaire-ccars-disabilitiesQuestionnaire CCARS Disabilitiesdraft1pahl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1099.49Disability Status Assessmentactive2024-08hl7
hl7.fhir.us.military-serviceR4ValueSet/military-service-discharge-status-vsDischarge Status Value Setactive2023-05hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.909Diseaseactive2019-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7970Disease Stage (Brucellosis)active2021-01
fhir.org.nz.ig.baseR4ValueSet/dhbDistrict Health Board Identiferactive2025-06hl7
hl7.fhir.us.splR5ValueSet/splDocumentCodesSPL Document Codestrial-use1brr2025-07hl7
signal.core.r4R4ValueSet/signal-filerepo-docreviewstatusSignal FileRepo DocStatusdraft2023-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1222.672Entrapment Neuropathyactive2024-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.228Low Emetic Risk Intravenous Antineoplastic Agentactive2025-04hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.271.12.37696.1.1.999.654Proton Pump Inhibitors not including for H. pylori treatmentactive2019-04hl7
fhir.org.nz.ig.baseR4ValueSet/domicile-codeDomicile Codeactive2025-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7927Dose Unit (STD)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7630Drinking Water (FDD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1071Drug Susceptibility Test Result Nameactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1102Drug Active Ingredientsactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1108Drug Classes (NDF-RT)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1106Drug Manufacturers (NDC)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7467Drug Disease Interaction (Dengue)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7055Antituberculosis Drugs (TB)active2013-01
hl7.fhir.us.breast-radiologyR4ValueSet/DuctAbnormalityTypeVSDuct Abnormality Type ValueSetactive2022-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.14914Race Value Setactive2024-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7926Number of Cigarettes Smoked per Day (CO)active2019-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.292Metabolic syndrome I10active2023-09hl7
hl7.fhir.us.registry-protocolsR4ValueSet/STEMIFirstNotedSTEMI or STEMI Equivalent First Notedactivecic2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.232EGFR Molecular Variants Amivantamab PMactive2024-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.231EGFR Amivantamab Molecular Variantsactive2024-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.56Early and Limited Stageactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.57Early Stage IIB or loweractive2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/ElectrocardiacAbnormalityTypeElectrocardiac Abnormality Typeactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/ElectrocardiacAssessmentMethodElectrocardiac Assessment Methodactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/ElectrocardiacAssessmentResultsElectrocardiac Assessment Resultsactivecic2023-11hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.985Employment Statusactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1011Data Subtypeactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1012Type of Dataactive2008-01
fhir.outburn.co.ilR4ValueSet/vs-encounter-admit-sourceEncounter Admit Sourcedrafthl7
ca.on.dhdr.r4.v4R4ValueSet/encounter-classEncounter Classactivehl7
fhir.outburn.co.ilR4ValueSet/vs-encounter-classEncounter Classdrafthl7
fhir.cdc.opioid-cds-r4R4ValueSet/condition-encounter-diagnosis-categoryEncounter Diagnosis Condition Categoryactive2023-05hl7
fhir.outburn.co.ilR4ValueSet/vs-encounter-statusEncounter Statusdrafthl7
hl7.fhir.us.directory-queryR4ValueSet/EndpointConnectionTypeVSEndpoint Connection Types Value Setactive2022-12hl7
hl7.fhir.us.davinci-pdex-plan-netR4ValueSet/EndpointConnectionTypeVSEndpoint Connection Types VStrial-usefm2025-02hl7
hl7.fhir.us.ndhR4ValueSet/EndpointConnectionTypeVSEndpoint Connection Types Value Settrial-usepa2025-07hl7
hl7.fhir.us.ndhR4ValueSet/EndpointFhirMimeTypeVSEndpoint FHIR Mimetype Value Settrial-usepa2025-07hl7
hl7.fhir.us.ndhR4ValueSet/EndpointIheSpecificConnectionTypeVSEndpoint IHE Specific Connection Types Value Settrial-usepa2025-07hl7
hl7.fhir.us.directory-queryR4ValueSet/EndpointPayloadTypeVSEndpoint Payload Type Value Setactive2022-12hl7
hl7.fhir.us.davinci-pdexR4ValueSet/EndpointPayloadTypeVSEndpoint Payload Type Value Settrial-use2fm2025-06hl7
hl7.fhir.us.davinci-pdex-plan-netR4ValueSet/EndpointPayloadTypeVSEndpoint Payload Types VStrial-usefm2025-02hl7
hl7.fhir.us.ndhR4ValueSet/EndpointPayloadTypeVSEndpoint Payload Type Value Settrial-usepa2025-07hl7
signal.core.r4R4ValueSet/questionnaire-ccars-enrollment-payerQuestionnaire CCARS Enrollment Payerdraft1pahl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1095.58Nutrition Order Item Groupingactive2018-04hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3129Injury Occurred Environment (VPD)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7674Lab Test Interpretation (Trich)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7744Lab Test Interpretation (TB)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7734Lab Test Interpretation (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7867Test Result (C. auris)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3252Lab Test Interpretation (Flu)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7823Lab Test Interpretation (Legionellosis)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7334Lab Test Interpretation (Pertussis)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3301Lab Test Interpretation (VPD)active2022-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3263Lab Test Interpretation (Pediatric Flu)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3251Lab Test Procedure (Flu)active2009-01